Language:

Status of vaccine research and development of vaccines for leishmaniasis

Vaccine, 2016-06, Vol.34 (26), p.2992-2995 [Peer Reviewed Journal]

Full text available

Citations Cited by

Title:
Status of vaccine research and development of vaccines for leishmaniasis
Author: Gillespie, Portia M ; Beaumier, Coreen M ; Strych, Ulrich ; Hayward, Tara ; Hotez, Peter J ; Bottazzi, Maria Elena
Subjects: Allergy and Immunology ; Animals ; Biomedical Research - trends ; Clinical Trials as Topic ; Fatalities ; Humans ; Leishmania ; Leishmaniasis ; Leishmaniasis - prevention & control ; Leishmaniasis Vaccines - therapeutic use ; Leishmaniasis, Cutaneous - prevention & control ; Leishmaniasis, Visceral - prevention & control ; Neglected tropical diseases ; NTDs ; Parasites ; Parasitic diseases ; Product development ; Protozoa ; Psychodidae - parasitology ; Tropical diseases ; Vaccines ; Vaccines, Synthetic - therapeutic use
Is Part Of: Vaccine, 2016-06, Vol.34 (26), p.2992-2995
Description: Highlights • Leishmaniasis accrues more than 50,000 deaths and 3.3 million DALYs annually. • There is currently no licensed vaccine against human leishmaniasis. • A vaccine will elicit long-lasting immunity and limit chemotherapy usage. • Recombinant protein-based and DNA-based vaccines are reviewed.
Publisher: Netherlands: Elsevier Ltd
Language: English
Identifier: ISSN: 0264-410X
EISSN: 1873-2518
DOI: 10.1016/j.vaccine.2015.12.071
PMID: 26973063
Source: MEDLINE
ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Searching Remote Databases, Please Wait